Synerkine Pharma

Utrecht, The Netherlands

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

$5.6M raised

Oct 2023

Series A

Biotechnology Health Care

Top Investors

InnovationQuarterThuja CapitalNetherlands Enterprise AgencyFlerie InvestUtrecht Health Seed Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Synerkine Pharma

How much funding has Synerkine Pharma raised?

Synerkine Pharma has raised $5.6M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are Synerkine Pharma's investors?

Synerkine Pharma's investors include InnovationQuarter, Thuja Capital, Netherlands Enterprise Agency, Flerie Invest, Utrecht Health Seed Fund.

Where is Synerkine Pharma headquartered?

Synerkine Pharma is headquartered in Utrecht, The Netherlands.

What does Synerkine Pharma do?

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

What stage is Synerkine Pharma at?

Synerkine Pharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 12, 2023.

MLA

"Synerkine Pharma — Funding & Investors." VCBacked, October 12, 2023, https://www.vcbacked.co/company/synerkine-pharma. Accessed June 17, 2026.

APA

VCBacked. (2023). Synerkine Pharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/synerkine-pharma

Wikipedia (cite web)

{{cite web |title=Synerkine Pharma — Funding & Investors |url=https://www.vcbacked.co/company/synerkine-pharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 12, 2023.

Similar Companies in Biotechnology